Skip to main content
CriticalFDAfda-F-0857-2013OTHER

La Madeleine Potato Soup, 5 lb clear Cryovac pouches, 4 pouches per case.

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (other). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
127
Recall Date
August 27, 2012
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0857-2013.

The potato in the potato soup is treated with sulfites. Sulfites were not declared on the firm's product label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0857-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Gourmet Cuisine, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0857-2013.

Gourmet Cuisine, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Gourmet Cuisine, Inc. Recall FAQ

Gourmet Cuisine, Inc. is the subject of a food safety report: La Madeleine Potato Soup, 5 lb clear Cryovac pouches, 4 pouches per case.. The notice was published on August 27, 2012 by the U.S. Food and Drug Administration (FDA). Approximately 127 units are potentially affected.